Inaxaplin

CAS No. 2446816-88-0

Inaxaplin ( VX-147 )

Catalog No. M28276 CAS No. 2446816-88-0

Inaxaplin is an apolipoprotein L1 ( APOL1 ) function inhibitor (WO2020131807, compound 2). Inaxaplin can be used for the research of kidney disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 372 Get Quote
5MG 620 Get Quote
10MG 881 Get Quote
25MG 1314 Get Quote
50MG 1764 Get Quote
100MG 2385 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Inaxaplin
  • Note
    Research use only, not for human use.
  • Brief Description
    Inaxaplin is an apolipoprotein L1 ( APOL1 ) function inhibitor (WO2020131807, compound 2). Inaxaplin can be used for the research of kidney disease.
  • Description
    Inaxaplin is an apolipoprotein L1 ( APOL1 ) function inhibitor (WO2020131807, compound 2). Inaxaplin can be used for the research of kidney disease.(In Vitro):Inaxaplin is an apolipoprotein L1 function inhibitor.
  • Synonyms
    VX-147
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    14-3-3 protein-protein interaction
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2446816-88-0
  • Formula Weight
    417.4
  • Molecular Formula
    C21H18F3N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mancini M, et al. A new nonpeptidic inhibitor of 14-3-3 induces apoptotic cell death in chronic myeloid leukemia sensitive or resistant to imatinib. J Pharmacol Exp Ther. 2011 Mar;336(3):596-604.
molnova catalog
related products
  • (+)-Puerol B 2-O-glu...

    (+)-Puerol B 2''-O-glucoside is a natural product for research related to life sciences.

  • Bacopaside X

    Bacopaside X (9.06 μM) showed binding affinity towards the D1 receptor.

  • Ethyl oleate

    Ethyl oleate is the liquid lipid component in nanostructured lipid carriers (NLCs).?NLC is a promising vehicle for oral trans-Ferulic acid (TFA) administration.?